Evolution to pathogenicity of the parvovirus minute virus of mice in immunodeficient mice involves genetic heterogeneity at the capsid domain that determines tropism

Journal of Virology

Volumn 82, Issue 3, 2008, Pages 1195-1203

  López Bueno, Alberto ^a   Segovia, José C ^d   Bueren, Juan A ^d   O'Sullivan, M Gerard ^c   Wang, Feng ^b,e   Tattersall, Peter ^b   Almendral, José M ^a  

^a CSIC   (Spain)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d CIEMAT   (Spain)

^e THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GLUTAMIC ACID; PROTEIN VP2; SIALIC ACID;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL INCLUSION; CELL LINE; CELL POPULATION; CONTROLLED STUDY; DNA VIRUS; FIBROBLAST; GENE EXPRESSION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENOTYPE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKOPENIA; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MOUSE; NATURAL HOST; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; SCID MOUSE; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; VIRAL GENETICS; VIROGENESIS; VIRUS CAPSID; VIRUS CULTURE; VIRUS MUTANT; VIRUS STRAIN; VIRUS VIRULENCE;

AMINO ACID SUBSTITUTION; ANIMALS; CAPSID PROTEINS; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; FEMALE; MICE; MICE, SCID; MINUTE VIRUS OF MICE; MUTANT PROTEINS; PARVOVIRIDAE INFECTIONS; PLAQUE ASSAY; VARIATION (GENETICS); VIRULENCE;

DNA VIRUSES; MAMMALIA; MINUTE VIRUS OF MICE; MIRIDAE; MUS; PARVOVIRUS;

EID: 38349138014     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01692-07     Document Type: Article

References (52)

1. Agbandje-McKenna, M., A. L. Llamas-Sainz, F. Wang, P. Tattersall, and M. G. Rossmann. 1998. Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure 6:1369-1381.
2. Antonietti, J.-P., R. Sahli, P. Beard, and B. Hirt. 1988. Characterization of the cell type-specific determinant in the genome of minute virus of mice. J. Virol. 62:552-557.
3. Astell, C. R., M. E. Gardiner, and P. Tattersall. 1986. DNA sequence of the lymphotropic variant of minute virus of mice, MVM3(i), and comparison with the DNA sequence of the fibrotropic prototype strain. J. Virol. 57:656-669.
4. Ball-Goodrich, L. J., and P. Tattersall. 1992. Two amino acid substitutions within the capsid are coordinately required for acquisition of fibrotropism by the Iymphotropic strain of minute virus of mice. J. Virol. 66:3415-3423.
5. Baranowski, E., C. M. Ruiz-Jarabo, and E. Domingo. 2001. Evolution of cell recognition by viruses. Science 292:1102-1105.
6. Bernard, H. 1994. Coevolution of papillomaviruses with human populations. Trends Microbiol. 2:140-143.
7. Biebricher, C. K., and M. Eigen. 2006. What is a quasispecies? Curr. Top. Microbiol. Immunol. 299:1-31.
8. Bonnard, G. D., E. K. Manders, D. A. Campbell, R. B. Herberman, and M. J. Collins. 1976. Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. J. Exp. Med. 143:187-205.
9. Bosnia, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527-530.
10. Brownstein, D. G., A. L. Smith, R. O. Jacoby, E. A. Johnson, G. Hansen, and P. Tattersall. 1991. Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype. Lab. Investig. 65:357-363.
11. Colomar, M. C., B. Hirt, and P. Beard. 1998. Two segments in the genome of the immunosuppressive minute virus of mice determine the host-cell specificity, control viral DNA replication and affect viral RNA metabolism. J. Gen. Virol. 79:581-586.
12. Cotmore, S. F., and P. Tattersall. 1987. The autonomously replicating parvoviruses of vertebrates. Adv. Virus Res. 33:91-173.
13. Crawford, L. V. 1966. A minute virus of mice. Virology 29:605-612.
14. D'Abramo, A. M., Jr., A. A. Ali, F. Wang, S. F. Cotmore, and P. Tattersall. 2005. Host range mutants of minute virus of mice with a single VP2 amino acid change require additional silent mutations that regulate NS2 accumulation. Virology 340:143-154.
15. Domingo, E., and J. J. Holland. 1997. RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51:151-178.
16. Domingo, E. 2007. Virus evolution, p. 389-421. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
17. Drake, J. W. 1991. A constant rate of spontaneous mutations in DNA-based microbes. Proc. Natl. Acad. Sci. USA 88:7160-7164.
18. Drake, J. W., and J. J. Holland. 1999. Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. USA 96:13910-13913.
19. Gao, G., M. R. Alvira, S. Somanathan, Y. Lu, L. H. Vandenberghe, J. J. Rux, R. Calcedo, J. Sanmiguel, Z. Abbas, and J. M. Wilson. 2003. Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl. Acad. Sci. USA 100:6081-6086.
20. Gardiner, E. M., and P. Tattersall. 1988. Mapping of the fibrotropic and lymphotropic host range determinats of the parvovirus minute virus of mice. J. Virol. 62:2605-2613.
21. Hueffer, K., J. S. L. Parker, W. Weicher, R. E. Geisesel, J.-Y. Sgro, and C. R. Parrish. 2003. The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor. J. Virol. 77:1718-1726.
22. Kimsey, P. B., H. D. Engers, B. Hirt, and V. Jongeneel. 1986. Pathogenicity of fibroblast- and lymphocyte-specific variants of minute virus of mice. J. Virol. 59:8-13.
23. Kontou, M., L. Govindasamy, H.-J. Nam, N. Bryant, A. L. Llamas-Saiz, C. Foces-Foces, E. Hernando, M.-P. Rubio, R. McKenna, J. M. Almendral, and M. Agbandje-McKenna. 2005. Structural determinants of tissue tropism and in vivo pathogenicity for the parvovirus minute virus of mice. J. Virol. 79:10931-10943.
24. Lednicky, J., A. Arrington, A. R. Stewart, X. M. Dai, C. Wong, S. Jafar, M. Murphey-Corb, and J. S. Butel. 1998. Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J. Virol. 72:3980-3990.
25. Lombardo, E., J. C. Ramírez, J. García, and J. M. Almendral. 2002. Complementary roles of multiple nuclear targeting signals in the capsid proteins of the parvovirus minute virus of mice during assembly and onset of infec-tion. J. Virol. 76:7049-7059.
26. López-Bueno, A., M. Mateu, and J. M. Almendral. 2003. High mutant frequency in populations of a DNA virus allows evasion from antibody therapy in an immunodeficient host. J. Virol. 77:2701-2708.
27. López-Bueno, A., N. Valle, J. M. Gallego, J. Pérez, and J. M. Almendral. 2004. Enhanced cytoplasmic sequestration of the nuclear export receptor CRM1 by NS2 mutations developed in the host regulates parvovirus fitness. J. Virol. 78:7049-7059.
28. López-Bueno, A., M. P. Rubio, N. Bryant, R. McKenna, M. Agbandje-McKenna, and J. M. Almendral. 2006. Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence. J. Virol. 80:1563-1573.
29. López-Bueno, A., L. P. Villarreal, and J. M. Almendral. 2006. Parvovirus variation for disease: a difference with RNA viruses? Curr. Top. Microbiol. Immunol. 299:349-370.
30. Lukashov, V., and J. Goudsmit. 2001. Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses. J. Virol. 75:2729-2740.
31. Martin, J., G. Dunn, R. Hull, V. Patel, and P. D. Minor. 2000. Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J. Virol. 74:3001-3010.
32. Maxwell, I. H., A. L. Spitzer, F. Maxwell, and D. J. Pintel. 1995. The capsid determinant of fibrotropism for the MVMp strain of minute virus of mice functions via VP2 and not VP1. J. Virol. 69:5829-5832.
33. Merchlinsky, M. J., P. J. Tattersall, J. J. Leary, S. F. Cotmore, E. M. Gardiner, and D. C. Ward. 1983. Construction of an infectious molecular clone of the autonomous parvovirus minute virus of mice. J. Virol. 47:227-232.
34. Nam, H. J., B. Gurda-Whitaker, W. Y. Gan, S. Ilaria, R. McKenna, P. Mehta, R. A. Alvarez, and M. Agbandje-McKenna. 2006. Identification of the sialic acid structures recognized by minute virus of mice and the role of binding affinity in virulence adaptation. J. Biol. Chem. 281:25670-25677.
35. Parrish, C. R., C. F. Aquadro, M. L. Strassheim, J. F. Evermann, J. Y. Sgro, and H. O. Mohammed. 1991. Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J. Virol. 65:6544-6552.
36. Ramírez, J. C., A. Fairén, and J. M. Almendral. 1996. Parvovirus minute virus of mice strain i multiplication and pathogenesis in the newborn mouse brain is restricted to proliferative areas and to migratory cerebellar young neurons. J. Virol. 70:8109-8116.
37. Reguera, J., E. Grueso, A. Carreira, C. Sanchez-Martinez, J. M. Almendral, and M. G. Mateu. 2005. Functional relevance of amino acid residues involved in interactions with ordered nucleic acid in a spherical virus. J. Biol. Chem. 280:17969-17977.
38. Ron, D., and J. Tal. 1985. Coevolution of cells and virus as a mechanism for the persistence of lymphotropic minute virus of mice in L-cells. J. Virol. 55:424-430.
39. Rubio, M.-P., A. López-Bueno, and J. M. Almendral. 2005. Virulent variants emerging in mice infected by the apathogenic prototype strain of the parvovirus MVM exhibit a capsid of low avidity for a primary receptor. J. Virol. 79:11280-11290.
40. Sayle, R. A., and E. J. Milner-White. 1995. RasMol: biomolecular graphics for all. Trends Biochem. Sci. 20:374-376.
41. Segovia, J. C., A. Real, J. A. Bueren, and J. M. Almendral. 1991. In vitro myelosuppressive effects of the parvovirus minute virus of mice (MVMi) on hematopoietic stem and committed progenitor cells. Blood 77:980-988.
42. Segovia, J. C., G. Guenechea, J. M. Gallego, J. M. Almendral, and J. A. Bueren. 2003. Parvovirus infection suppresses long-term repopulating hematopoietic stem cells. J. Virol. 77:8495-8503.
43. Segovia, J. C., J. M. Gallego, J. A. Bueren, and J. M. Almendral. 1999. Severe leukopenia and dysregulated erythropoiesis in SCID mice persistently infected by the parvovirus minute virus of mice. J. Virol. 73:1774-1784.
44. Shackelton, L. A., C. R. Parrish, U. Truyen, and E. C. Holmes. 2005. High rate of viral evolution associated with the emergence of carnivore parvovirus. Proc. Natl. Acad. Sci. USA 102:379-384.
45. Shackelton, L. A., and E. C. Holmes. 2006. Phylogenese evidence for the rapid evolution of human B19 erythrovirus. J. Virol. 80:3666-3669.
46. Shankarappa, R., J. B. Margolick, S. J. Gange, A. G. Rodrigo, D. Upchurch, H. Farzadegan, P. Gupta, C. R. Rinaldo, G. H. Learn, X. He, X. L. Huang, and J. I. Mullins. 1999. Consistent viral evolutionary changes associated with populations of human immunodeficiency virus type 1 infection. J. Virol. 73:10489-10502.
47. Spalholz, B. A., and P. Tattersall. 1983. Interaction of minute virus of mice with differentiated cells: strain-dependent target cell specificity is mediated by intracellular factors. J. Virol. 46:937-943.
48. Tattersall, P., A. J. Shatkin, and D. C. Ward. 1977. Sequence homology between the structural polypeptides of minute virus of mice. J. Mol. Biol. 111:375-394.
49. Tattersall, P., and J. Bratton. 1983. Reciprocal productive and restrictive virus-cell interaction of immunosuppressive and prototype strains of minute virus of mice. J. Virol. 46:944-955.
50. Tattersall, P. 2006. The evolution of parvovirus taxonomy, p. 5-16. In J. Kerr, S. F. Cotmore, M. E. Bloom, R. M. Linden, and C. R. Parrish (ed.), The parvoviruses. Hodder Arnold, London, United Kingdom.
51. Vignuzzi, M., J. K. Stone, J. J. Arnold, C. E. Cameron, and R. Andino. 2006. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439:344-348.
52. Wolinsky, S. M., B. T. M. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup. 1996. Adaptative evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.